Clorox (CLX) Tops Q3 EPS by 10c; Lifts Outlook
Get Alerts CLX Hot Sheet
Revenue Growth %: -2.6%
Financial Fact:
Selling and administrative expenses: 200M
Today's EPS Names:
SFST, VLTO, CLIR, More
Join SI Premium – FREE
Clorox (NYSE: CLX) reported Q3 EPS of $1.21, $0.10 better than the analyst estimate of $1.11. Revenue for the quarter came in at $1.43 billion versus the consensus estimate of $1.41 billion.
"Our 2020 strategy continues to deliver strong results," said Chief Executive Officer Benno Dorer. "Increased demand-building investments, including awareness and trial support behind product innovation, drove sales increases across all of our U.S. segments and in International on a currency-neutral basis. Importantly, we continue to drive gains in our market shares and categories."
GUIDANCE:
Clorox sees FY2016 EPS of $4.85-$4.95, versus prior guidance of $4.75-$4.90 and the consensus of $4.93. Sees 1% to 2% sales growth, or 4% to 5% currency-neutral (previously flat to 1% growth, 3% to 4% currency neutral). About 50 basis points of EBIT margin expansion (previously 50-75 basis points)
For earnings history and earnings-related data on Clorox (CLX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Philip Morris (PM) beats Q1 earnings, revenue estimates; issues upbeat guidance
- Sherwin-Williams (SHW) Misses Q1 EPS by 5c, provides guidance
- Lockheed Martin (LMT) Tops Q1 EPS by 59c, Beats on Revenue; Offers FY24 Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Management CommentsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!